Tweet from EricTopol at November 20, 2022 at 07:45AM

Why is the outlook favorable when new variants with marked immune evasion and growth advantage have become dominant?
https://t.co/DqMJ7LSJZC

— Eric Topol (@EricTopol)
Nov 20, 2022

from http://twitter.com/EricTopol